Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Alcoholic Fatty Liver Disease (NAFLD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT05474560
What this trial is testing

Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD Patients

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseHyperuricemia
Ain Shams University 90
Early research (Phase 1)Study completedNCT03392779
What this trial is testing

Study in Chinese Healthy Adults to Evaluate the Safety, Tolerability and Pharmacokinetics on ZSP1601, and the Effect of Food on ZSP1601 Pharmacokinetics

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Guangdong Zhongsheng Pharmaceutical Co., Ltd. 94
Not applicableUnknownNCT04543721
What this trial is testing

24-h-ambulatory Blood Pressure Monitoring and Pulse Wave Analysis in NAFLD Patients

Who this might be right for
NAFLD; Hypertension, White-coat Hypertension, Masked Hypertension
University Hospital of Cologne 200
Testing effectiveness (Phase 2)Ended earlyNCT03329885
What this trial is testing

Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis

Who this might be right for
Rheumatoid ArthritisPsoriasisAnkylosing Spondylitis+2 more
Bristol-Myers Squibb 38
Not applicableStudy completedNCT03738358
What this trial is testing

Clinical Study of 12-week Trehalose Intake in Patients With Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver
Samsung Medical Center 39
Large-scale testing (Phase 3)Study completedNCT03723252
What this trial is testing

Dapagliflozin Efficacy and Action in NASH

Who this might be right for
Nonalcoholic Steatohepatitis
Nanfang Hospital, Southern Medical University 154
Not applicableActive Not RecruitingNCT05499949
What this trial is testing

The Franciscus Obesity NASH Study

Who this might be right for
NAFLDNASH - Nonalcoholic SteatohepatitisObesity, Morbid
Franciscus Gasthuis 300
Not applicableStudy completedNCT02686476
What this trial is testing

Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 Diabetes

Who this might be right for
Non Alcoholic Fatty Liver Disease
Medanta, The Medicity, India 100
Not applicableLooking for participantsNCT03875625
What this trial is testing

Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseObesity, MorbidBrown Fat+4 more
Chinese University of Hong Kong 80
Not applicableLooking for participantsNCT07658755
What this trial is testing

Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseLiver FibrosisNon-alcoholic Fatty Liver Disease NAFLD+3 more
Hospital General Universitario Gregorio Marañon 3,000
Not applicableActive Not RecruitingNCT05275608
What this trial is testing

Effects of VLCKD in Metabolic Syndrome

Who this might be right for
Diabetes Mellitus, Type 2Non-alcoholic Fatty Liver DiseaseObesity+1 more
Azienda Ospedaliero Universitaria Maggiore della Carita 40
Early research (Phase 1)Ended earlyNCT04565717
What this trial is testing

ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic SteatohepatitisNASH
Alnylam Pharmaceuticals 6
Testing effectiveness (Phase 2)Study completedNCT04048135
What this trial is testing

A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH

Who this might be right for
NASH
89bio, Inc. 101
Not applicableUnknownNCT05907408
What this trial is testing

Omics Techniques in Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Universidade Federal do Rio de Janeiro 10
Early research (Phase 1)UnknownNCT05063968
What this trial is testing

A Clinical Trial of XZP-6019 Tablets in Healthy Subjects

Who this might be right for
Non-alcoholic Fatty Liver Disease
Xuanzhu Biopharmaceutical Co., Ltd. 120
Not applicableUnknownNCT02391168
What this trial is testing

Fatty Liver Disease Collaborative Research in China

Who this might be right for
Fatty LiverFatty Liver, AlcoholicNon-alcoholic Fatty Liver Disease
Fatty Liver and Alcoholic Liver Disease Study Group, China 3,000
Testing effectiveness (Phase 2)Study completedNCT01679197
What this trial is testing

Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy

Who this might be right for
Fatty Liver Disease, NonalcoholicNonalcoholic SteatohepatitisLipodystrophy
University of Michigan 23
Not applicableStudy completedNCT01761370
What this trial is testing

Intragastric Balloon for Treatment of Non Alcoholic Steatohepatitis (NASH)

Who this might be right for
Non Alcoholic Steatohepatitis
National University Hospital, Singapore 21
Not applicableStudy completedNCT04059068
What this trial is testing

Macrophage-mediated Inflammation in White Adipose Tissue and Non-alcoholic Fatty Liver Disease.

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Imperial College London 48
Not applicableLooking for participantsNCT04807868
What this trial is testing

AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)

Who this might be right for
Non-Alcoholic Fatty Liver Disease
AdventHealth Translational Research Institute 1,250
Next Page